Nextrials, InClin partner to provide next gen clinical research services

Wednesday, October 10, 2012 10:38 AM

Nextrials, a clinical research software and services company based in San Ramon, Calif., has formed a partnership with InClin, a specialized CRO of Los Altos, Calif., to provide next generation clinical research services.

Researchers can take full advantage of each company’s strengths by linking Nextrials’ Prism, an award winning clinical trial data management platform, with InClin’s personalized, high-quality services to accelerate study starts and significantly lower drug development costs.

“Our companies have similar approaches to research, particularly when it comes to offering exceptional clinical trial performance and service,” said Dirk Thye, CEO of InClin. “We take pride in our ability to deliver superior data quality to our sponsors, and Nextrials’ Prism meets our high standards as an enabling data management platform that can significantly shorten the length of time it takes to initiate and monitor a clinical trial. Together, we can help sponsors attain high quality data and potentially expedite the path to approval.”

Prism, its design tools and its new iPad interface give pharmaceutical and biotech researchers anytime/anywhere access to key data points, reports and statistics about ongoing studies, regardless of location. It enables sponsors to better manage investigator site data, logistics and costs, including access to real-time data related to patient demographics, recruitment/enrollment status, queries and more.

“As clinical trials become more complex, partnerships such as this one remove some of the organizational and integration headaches from study initiation and monitoring,” said James Rogers, CEO and co-founder of Nextrials.  “Prism’s capabilities, combined with InClin’s senior project management team and its standardized performance indicators and quality metrics processes, give sponsors an edge in obtaining critical study data on a timely basis and keeping studies on track.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs